美国时间8月12日,辉瑞公布RSV疫苗Abrysvo的III期临床研究MONet研究免疫功能不全成年人群的顶线结果,结果显示18岁及以上免疫功能人群单剂接种RSV疫苗Abrysvo后具有良好的耐受性且能产生强烈的中和反应。 此次结果来自MONet研究(RSV IMmunization Study for...
The US Food and Drug Administration (FDA) has approved the first vaccine for respiratory syncytial virus (RSV) in the United States, the agency announced May 3. Arexvy, manufactured by GSK, is the world's first RSVvaccine for adults aged 60 years and older, the company said in an ...
In 2023, two respiratory syncytial virus (RSV) vaccines became available in the United States (US) for adults aged ≥60 years and were recommended by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices using shared clinical decision-making (i.e., ...
They also recommended vaccination for adults aged 60 to 74 years with risk factors for severe RSV. The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus. The Advisory Committee on Immuniza...
Respiratory syncytial virus (RSV) can infect adults and children. Common signs of RSV include cough and runny nose. Here’s all you need to know about symptoms, tests, and treatment.
2023 ACIP Updates for Immunizations in Adults and Children: What Pharmacists Need to Know Optimizing Patient Visits: Implementing Immunizations Into the Ambulatory Clinic Workflow Improving Vaccination Rates Among Adults and Young Adults You Mean We Should Do This Year-Round?Related Videos ...
On August 6, 2024, the United States Centers for Disease Control and Prevention updated itsrecommendations for respiratory syncytial virus (RSV)vaccines in adults ages 60 and older. The updated recommendations are based on a vote from the Advisory Committee on Immunization Practices...
The first vaccines to guard against therespiratory illness RSVwill soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots. The move, announced Thursday, followed a vote at ameetingof the CDC's Advisory Committee on Immunization Prac...
Despite this RSV season having a "game-changing" new set of vaccinations and immunizations, doctors say uptake has lagged among adults and children. 1 year ago What happened to the RSV shots for babies? While the virus usually causes mild, cold-like symptoms, up to 80,000 children younger...
RSV mostly affects children under 2, but it can be serious in adults over 65 who are immunocompromised or have chronic conditions. Here’s why. “No vaccine is 100 percent effective. An 80 percent vaccine effectiveness rate is quite impressive and higher than we see, for example, with the ...